wegovy novo nordisk - Search News

News

Novo Nordisk shares dip further

Novo Nordisk shares dip further as Wegovy gains nearly erased

By Jacob Gronholt-Pedersen (Reuters) -Shares in Novo Nordisk fell as much as 6% on Friday before recovering some ground later in the session, extending recent losses that threaten to wipe out all the gains since the drugmaker launched its blockbuster weight-loss treatment Wegovy four years ago.

The Wall Street Journal on MSN · 2d

Novo Nordisk Shares Plummet as Competition Weighs on Sales

The pharmaceutical giant cut its guidance and said U.S. sales of Ozempic grew more slowly.

CNBC on MSN · 3d

Novo Nordisk shares plunge 23% after Wegovy maker names new CEO, cuts full-year guidance

Danish pharmaceutical giant Novo Nordisk on Tuesday cut its full-year sales and profit guidance, citing weaker growth expectations for its Wegovy obesity drug in the key U.S. market. Shares were down 17% at 12:30 p.m. London time, shortly after the announcement (7:30 a.m. ET).

4hon MSN

Why Novo Nordisk Stock Imploded This Week

Shares of Novo Nordisk ( NVO 2.48%) are falling this week, down 33% as of 3:27 p.m. ET on Friday. The drop comes as the S&P ...

3don MSN

Wegovy maker Novo's profit warning triggers $70 billion share rout

Investors wiped $70 billion off Novo Nordisk's market value on Tuesday after the maker of weight-loss drug Wegovy issued a ...

Novo Nordisk stock posts worst week since 2021, but analysts see a bigger problem ahead

Novo Nordisk stock plunges 30% after forecast cut, CEO shakeup, and rising competition hit investor confidence.

Devdiscourse7h

Novo Nordisk Faces Turbulence Amid U.S. Drug Pricing Pressure

Novo Nordisk shares fell significantly due to pressure from U.S. President Donald Trump to cut drug prices, and competition ...

2don MSN

Novo Nordisk slides further on US competition, new CEO concerns

Shares in Wegovy maker Novo Nordisk fell further on Wednesday as analysts warned of persistent competition from copycat drugs ...

3hon MSN

Why Novo Nordisk Stock Bumped Higher on Friday

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

2don MSN

Novo Nordisk cuts 2025 outlook and names new CEO on weak Wegovy sales

CNBC's Karen Gilchrist discusses Novo Nordisk's new CEO and the pharma giant's move to cut its full-year guidance on weaker ...

WSKG2d

Drugmaker Novo Nordisk slashes Wegovy sales forecasts, blaming compounding

Compounding pharmacies are crimping sales of Novo Nordisk's obesity drug Wegovy by making what are essentially copies of the ...

WFRV Local 5 on MSN5h

New tariffs could raise prices of Ozempic, Wegovy

Some of the most recognizable brand names that could be impacted by new tariffs include Ozempic and Wegovy, two injectable ...

10h

Can I take Wegovy while pregnant?

Weight loss medications like Wegovy can be life-changing for people living with obesity or excess weight with related health ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results